Rhode Island 2024 Regular Session

Rhode Island House Bill H8075

Introduced
3/15/24  

Caption

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

Impact

The bill's passing will have a significant impact on the accessibility of glucagon treatments for individuals in Rhode Island who suffer from diabetes. By eliminating financial barriers to obtaining glucagon auto-injectors, the legislation aims to enhance the management of hypoglycemia, thereby potentially improving clinical outcomes and reducing healthcare costs associated with uncontrolled diabetes. This measure reflects an understanding of the urgent nature of hypoglycemic episodes and the necessity for timely interventions, even by non-professional caregivers.

Summary

House Bill 8075 proposes an amendment to the insurance laws in Rhode Island to mandate that health insurance plans providing prescription benefits must cover glucagon auto-injectors or similar formulations designed to treat hypoglycemia, which is a condition often faced by individuals with diabetes. The bill specifies that such coverage should be available without any copayment or deductible for the first two glucagon auto-injectors or nasal sprays obtained every year starting January 1, 2025. This ensures that patients with diabetes can access these potentially life-saving medications quickly and affordably in emergency situations.

Contention

While the bill is expected to receive support from healthcare advocates due to its benefits for diabetic patients, it may face pushback from insurance companies concerned about the financial implications of mandating coverage without copayments or deductibles. Critics may raise concerns regarding the burden this places on insurers, particularly in the context of rising healthcare costs. Additionally, discussions surrounding such legislation often bring forth debates on the balance between ensuring patient access to essential medications and managing the financial responsibilities of health insurance providers.

Companion Bills

No companion bills found.

Similar Bills

RI S2626

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

RI H5173

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

RI S0115

Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.

UT SB0146

Glucagon Amendments

NJ S3278

Extends permission to administer glucagon and blood glucose tests to EMTs.

NJ A4280

Extends permission to administer blood glucose tests to EMTs.

UT HB0475

School Prescription Amendments

IL HB4294

PHARMACY-STANDING ORDER-SCHOOL